Literature DB >> 4062289

alpha-Ketobutyrate metabolism in perfused rat liver: regulation of alpha-ketobutyrate decarboxylation and effects of alpha-ketobutyrate on pyruvate dehydrogenase.

D S Lapointe, M S Olson.   

Abstract

The oxidative decarboxylation and subsequent production of glucose from alpha-ketobutyrate were studied using perfused livers from fasted rats. The production of 14CO2 from alpha-keto-[1-14C]butyrate increased monotonically while the production of glucose from alpha-ketobutyrate was biphasic as the perfusate concentration of alpha-ketobutyrate was increased. The biphasic gluconeogenic response using alpha-ketobutyrate as the gluconeogenic precursor was similar to that observed with propionate. The decarboxylation of alpha-ketobutyrate was found to be exquisitely sensitive to the effects of the monocarboxylate transport inhibitor, alpha-cyanocinnamate. Infusion of beta-hydroxybutyrate caused a substantial inhibition of alpha-ketobutyrate decarboxylation while dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, did not stimulate the metabolism of alpha-ketobutyrate but was inhibitory. The effects of alpha-ketobutyrate infusion on pyruvate decarboxylation were tested and it was found that at low perfusate pyruvate concentrations (ca. 0.25 mM) increasing alpha-ketobutyrate led to increasing inhibition of pyruvate decarboxylation, while at high perfusate pyruvate concentrations (ca. 2.5 mM) an initial inhibition was apparent which did not increase substantially with increasing alpha-ketobutyrate concentrations. The results obtained indicate that the regulation of alpha-ketobutyrate metabolism by oxidative decarboxylation differs significantly from that of pyruvate. In addition, while the rate of gluconeogenesis using alpha-ketobutyrate as a precursor was remarkably similar to that using propionate as a gluconeogenic precursor, the effects of alpha-ketobutyrate on the oxidative decarboxylation of pyruvate were qualitatively different from the effects of propionate on pyruvate metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4062289     DOI: 10.1016/0003-9861(85)90226-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Molecular characterization of the mde operon involved in L-methionine catabolism of Pseudomonas putida.

Authors:  H Inoue; K Inagaki; S I Eriguchi; T Tamura; N Esaki; K Soda; H Tanaka
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

2.  Carnitine metabolism in the vitamin B-12-deficient rat.

Authors:  E P Brass; S P Stabler
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

3.  Hyperpolarized [(13)C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms.

Authors:  Cornelius von Morze; Robert A Bok; Michael A Ohliger; Zihan Zhu; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2015-06-08       Impact factor: 4.668

4.  Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.

Authors:  E P Brass; R A Beyerinck
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  Untargeted metabolomics reveals a mild impact of remote ischemic conditioning on the plasma metabolome and α-hydroxybutyrate as a possible cardioprotective factor and biomarker of tissue ischemia.

Authors:  Mia Roest Laursen; Jakob Hansen; Casper Elkjær; Ninna Stavnager; Camilla Bak Nielsen; Kasper Pryds; Jacob Johnsen; Jan Møller Nielsen; Hans Erik Bøtker; Mogens Johannsen
Journal:  Metabolomics       Date:  2017-04-17       Impact factor: 4.290

6.  Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS.

Authors:  Teruo Miyazaki; Akira Honda; Tadashi Ikegami; Junichi Iwamoto; Tadakuni Monma; Takeshi Hirayama; Yoshifumi Saito; Kouwa Yamashita; Yasushi Matsuzaki
Journal:  Springerplus       Date:  2015-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.